Detalhe da pesquisa
1.
Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer.
Gynecol Oncol
; 174: 80-88, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37167896
2.
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.
Ann Oncol
; 26(9): 1941-1947, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109631
3.
Potential interactions with anticancer agents: a cross-sectional study.
Chemotherapy
; 59(2): 85-92, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23881290
4.
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.
Br J Cancer
; 107(3): 435-41, 2012 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22767144
5.
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers.
Ann Oncol
; 23(10): 2663-2670, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22473592
6.
Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion.
Facts Views Vis Obgyn
; 14(2): 111-120, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35781107
7.
Cancer and renal insufficiency results of the BIRMA study.
Br J Cancer
; 103(12): 1815-21, 2010 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21063408
8.
Treatment algorithm in patients with ovarian cancer.
Facts Views Vis Obgyn
; 12(3): 227-239, 2020 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123697
9.
A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.
J Visc Surg
; 157(2): 79-86, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837942
10.
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.
J Clin Oncol
; 12(7): 1458-67, 1994 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-7912725
11.
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.
J Clin Oncol
; 19(12): 3103-10, 2001 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11408507
12.
A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors.
Clin Cancer Res
; 6(1): 64-71, 2000 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-10656433
13.
Systemic treatment for locally advanced breast cancer: what we still need to learn after a decade of multimodality clinical trials.
Eur J Cancer
; 28(2-3): 667-72, 1992.
Artigo
em Inglês
| MEDLINE | ID: mdl-1591090
14.
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group.
Eur J Cancer
; 30A(8): 1061-4, 1994.
Artigo
em Inglês
| MEDLINE | ID: mdl-7654429
15.
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicity.
Cancer Chemother Pharmacol
; 40(5): 439-43, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9272122
16.
Inadvertent transfer of choriocarcinoma with renal transplantation: characteristics of the donor-recipient pairs.
Transplant Proc
; 27(2): 1789-90, 1995 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-7725506
17.
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.
Ann Oncol
; 18(4): 738-44, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17208931
18.
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.
Ann Oncol
; 16(12): 1898-905, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16219623
19.
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients.
Br J Cancer
; 78(10): 1342-5, 1998 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-9823976
20.
Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC).
Support Care Cancer
; 5(5): 414-6, 1997 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-9322355